# NEUBASE THERAPEUTICS INC (NBSE)

> Institutional ownership reported to the SEC as of Q2 2024, from Form 13F filings. Source: https://holderbook.com/stocks/NBSE/

- Reporting holders: 1
- Reported value: $5.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Baader Bank Aktiengesellschaft](https://holderbook.com/funds/1542629-baader-bank-aktiengesellschaft/) | $5.0K | 16,089 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2024 | 1 | $5.0K |
| Q1 2024 | 16 | $156.0K |
| Q4 2023 | 20 | $340.2K |
| Q3 2023 | 18 | $260.4K |
| Q2 2023 | 24 | $901.1K |
| Q2 2022 | 1 | $14.0K |
| Q1 2022 | 1 | $41.0K |
| Q4 2021 | 2 | $13.0K |
| Q3 2021 | 2 | $58.0K |
| Q2 2021 | 2 | $112.0K |
| Q1 2021 | 2 | $71.0K |
| Q4 2020 | 1 | $17.0K |